Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Oncodesign Precision Medicine

Biotech & Life Sciences · Dijon, France · Founded 1995 · IPO 2014 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$113M
Market cap · 2026
Revenue
$57M
Latest reported FY

Investors

3 investors on Oncodesign Precision Medicine's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 3 investors entered at this stage

Global footprint

Where Oncodesign Precision Medicine has talent and traffic

AI talent share
7.1% of workforce is AI talent
(1 of 14 staff)
Core AI17.14%
Other AI00%
Non-AI workforce1392.86%
Web traffic by country
1.4K monthly visits
across markets
🇫🇷 France78.6%
🇧🇪 Belgium21.4%
Top 2 markets shown

See Oncodesign Precision Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.